Cargando…

Neratinib for breast cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954866/
https://www.ncbi.nlm.nih.gov/pubmed/31937993
http://dx.doi.org/10.18773/austprescr.2019.074
_version_ 1783486862528086016
collection PubMed
description
format Online
Article
Text
id pubmed-6954866
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-69548662020-01-14 Neratinib for breast cancer Aust Prescr New Drugs NPS MedicineWise 2019-11-21 2019-12 /pmc/articles/PMC6954866/ /pubmed/31937993 http://dx.doi.org/10.18773/austprescr.2019.074 Text en (c) NPS MedicineWise 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Neratinib for breast cancer
title Neratinib for breast cancer
title_full Neratinib for breast cancer
title_fullStr Neratinib for breast cancer
title_full_unstemmed Neratinib for breast cancer
title_short Neratinib for breast cancer
title_sort neratinib for breast cancer
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954866/
https://www.ncbi.nlm.nih.gov/pubmed/31937993
http://dx.doi.org/10.18773/austprescr.2019.074